Picture of Tenax Therapeutics logo

TENX — Tenax Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Tenax Therapeutics Q2 Net Income USD -17.803 Million




BRIEF-Tenax Therapeutics Q2 Net Income USD -17.803 Million


Jul 31 (Reuters) - Tenax Therapeutics Q2 operating expenses USD 18.784 million.

  • Q2 operating income USD -18.784 million

Recent news on Tenax Therapeutics

See all news